02Aug
FDA Issues Cannabidiol Marketing Warning as Congressional Pressure for Action Continues
Following through with its promise to take enforcement actions against companies marketing cannabis-derived products that could put consumers at risk, the Food and Drug Administration (FDA) recently issued a warning letter to Curaleaf Inc., a...
By:
Wilson Sonsini Goodrich & Rosati
Related
Dangers That As A 401(k) Provider You Need To Avoid. In an instant, it can all be gone. It can tak...
Read More >
The U.S. District Court for the Eastern District of New York recently rejected the government’s arg...
Read More >
The U.S. Department of Labor makes available a variety of Family and Medical Leave Act forms to empl...
Read More >
September 1, 2019 may be seen as a new starting point for the enforcement of China’s antitrust and ...
Read More >
Welcome to Exiger week on Compliance and Coronavirus. In this episode, I visit with Michael Beber, t...
Read More >
On Tuesday, February 11, 2020, the Equal Employment Opportunity Commission filed a complaint against...
Read More >